Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFβ1

Journal of Cellular Physiology

Volumn 179, Issue 2, 1999, Pages 201-207

  Edmondson, Stephanie R ^c   Murashita, Mari M ^a   Russo, Vincenzo C ^c   Wraight, Christopher J ^c   Werther, George A ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA ANALYSIS; TRANSCRIPTION REGULATION;

CULTURE MEDIA, CONDITIONED; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; PEPTIDE FRAGMENTS; RNA, MESSENGER; SKIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032936350     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199905)179:2<201::AID-JCP10>3.0.CO;2-9     Document Type: Article

References (41)

1. Ballard FJ, Francis GL, Bagley CJ, Szabo L, Wallace JC. 1989. Effects of insulin-like growth factors on protein metabolism: why are some molecular variants more potent? Biochem Soc Symp 55:91-104.
2. Barreca A, deLuca M, delMonte P, Bondanza S, Damonte G, Cariola G, diMarco E, Giordano G, Cancedda R, Minuto F. 1992. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 151:262-268.
3. Batch JA, Mercuri FA, Edmondson SR, Werther GA. 1994. Localization of messenger ribonucleic acid for insulin-like growth factor binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 79:1444-1449.
4. Burgaud JL, Baserga R. 1996. Intracellular transactivation of the insulin-like growth factor-I receptor by an epidermal growth factor receptor. Exp Cell Res 223:412-419.
5. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Cohen P, Lamson G, Okajima T, Rosenfeld RG. 1993. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 7:380-386.
7. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R. 1994. A functional insulin-like growth factor receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14:4588-4595.
8. Erondu NE, Dake BL, Moser DR, Lin M, Boes M, Bar RS. 1996. Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta. Growth Regulation 6:1-9.
9. Grimes RW, Hammond JM. 1994. Proteolytic degradation of insulin-like growth factor (IGF)-binding protein-3 by porcine granulosa cells in culture: regulation by IGF-I. Endocrinology 134:337-343.
10. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. 1986. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138-143.
11. Jones J, Clemmons D. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-33.
12. Krane JF, Murphy DP, Carter DM, Krueger JG. 1991. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be modulated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 96:419-424.
13. Krane JF, Gottlieb AB, Carter DM, Krueger JG. 1992. The insulin-like growth factor I receptor is over-expressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J Exp Med 175:1081-1090.
14. Kummer JL, Zawada WM, Freed CR, Chernausek SD, Heidenreich KA. 1996. Insulin-like growth factor binding proteins in fetal rat mesenchephalic culture: regulation by fibroblast growth factor and insulin-like growth factor-I. Endocrinology 137:3551-3556.
15. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Lalou C, Silve C, Rosato R, Segovia B, Binoux M. 1994. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326.
17. Lalou C, Lassarre C, Binoux M. 1996. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology 137:3206-3212.
18. Leighton JK, Grimes RW, Canning SF, Hammond JM. 1994. IGF-binding proteins are differentially regulated in an ovarian granulosa cell line. Mol Cell Endocrinol 106:75-80.
19. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1r). Cell 75: 59-72.
20. Martin JL, Baxter RC. 1992. Transforming growth factor-β stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology 128:1425-1433.
21. Martin JL, Baxter RC. 1993. Release of fibroblast IGFBPs by TGF-beta and IGF-I occurs through distinct mechanisms. Growth Regulation 3:62-65.
22. Mosheni-Zadeh SM, Binoux M. 1997. The 16 kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type I IGF receptor gene. Endocrinology 138:3069-3072.
23. Murashita MM, Russo VC, Edmondson SR, Wraight CJ, Werther GA. 1995. Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes. J Cell Physiol 163: 339-345.
24. Neely EK, Rosenfeld RG. 1992. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells. Endocrinology 130:985-993.
25. Oh Y, Muller HL, Lamson G, Rosenfeld RG. 1993a. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268:14964-14971.
26. Oh Y, Muller HL, Pham H, Rosenfeld RG. 1993b. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048.
27. Oh Y, Muller HL, Ng L, Rosenfeld RG. 1995. Transforming growth factor-b-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 270:13589-13592.
28. Price WA, Moats-Staats BM, Stiles AD. 1995. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells. Am J Respir Cell Mol Biol 13:466-476.
29. Ramagnolo D, Akers RM, Byatt JC, Wong EA, Turner JD. 1994. IGF-I-induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cells. Mol Cell Endocrinol 102: 131-139.
30. Ristow HJ. 1996. Studies on stimulation of DNA synthesis with epidermal growth factor and insulin-like growth factor-I in cultured human keratinocytes. Growth Regulation 6:96-109.
31. Scharf J, Ramadori G, Braulke T, Hartmann H. 1996. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cell, and in cocultures: regulation by insulin, insulin-like growth factor, and growth hormone. Hepatology 23:818-827.
32. Schmid P, Cox D, Bilbe G, McMaster G, Morrison C, Stähelin H, Lüscher N, Seiler W. 1993. TGF-betas and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 171:191-197.
33. Shimasaki S, Ling N. 1991. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243-266.
34. Shipley GD, Pittelkow MR, Wille JJ, Scott RE, Moses HL. 1986. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum free medium. Cancer Res 46:2068-2071.
35. Spratt SK, Tatsuno GP, Yamanaka MK, Ark BC, Detmer J, Mascarenhas D, Flynn J, Talkington-Verser C, Spencer EM. 1990. Cloning and expression of human insulin-like growth factor binding protein 3. Growth Factors 3:63-72.
36. Tavakkol A, Elder JT, Griffiths CEM, Cooper KD, Talwar H, Fisher GJ, Keane KM, Foltin SK, Voorhees JJ. 1992. Expression of growth hormone receptor, insulin-like growth factor I (IGF-I) and IGF-I receptor mRNA and proteins in human skin. J Invest Dermatol 99:343-349.
37. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. 1995. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I-receptor gene. Mol Endocrinol 9:361-367.
38. Wraight CJ, Murashita MM, Russo VC, Werther GA. 1994. A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) which modulates insulin-like growth factor-I action. J Invest Dermatol 103:627-631.
39. Wraight CJ, Werther GA. 1995. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J Invest Dermatol 105:602-607.
40. Wraight CJ, Edmondson SR, Fortune DW, Varigos G, Werther GA. 1997. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in the psoriatic lesion. J Invest Dermatol 108:452-456.
41. Yateman ME, Claffey DC, Cwyfan-Hughes SC, Frost VJ, Wass JA, Holly JM. 1993. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. J Endocrinol 137:151-159.